Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LUNG | US
-0.14
-1.88%
Healthcare
Medical Devices
30/06/2024
04/10/2024
7.30
7.47
7.47
7.26
Pulmonx Corporation a commercial-stage medical technology company provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction fissure completeness and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States Europe the Middle East Africa the Asia-Pacific and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City California.
View LessLow Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
53.3%1 month
61.2%3 months
69.8%6 months
69.5%-
28.33
3.21
0.56
0.33
-5.62
3.48
-
-56.93M
285.81M
285.81M
-
-75.17
-
20.90
-49.22
5.86
6.52
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.48
Range1M
2.48
Range3M
3.33
Rel. volume
0.33
Price X volume
625.04K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Nyxoah SA | NYXH | Medical Instruments & Supplies | 9.09 | 312.45M | -1.73% | n/a | 10.60% |
Cellpoint Inc | CLPT | Medical Devices | 11.21 | 309.35M | 2.75% | n/a | 42.94% |
OraSure Technologies Inc | OSUR | Medical Instruments & Supplies | 4.14 | 308.71M | -0.24% | 11.92 | 2.96% |
Sight Sciences Inc. | SGHT | Medical Devices | 5.81 | 292.29M | -5.99% | n/a | 34.46% |
Zynex Inc | ZYXI | Medical Devices | 7.9 | 250.77M | -0.63% | 45.00 | 228.46% |
AngioDynamics Inc | ANGO | Medical Instruments & Supplies | 6.1 | 247.87M | -20.26% | n/a | 2.88% |
Utah Medical Products Inc | UTMD | Medical Instruments & Supplies | 65.05 | 226.19M | -0.85% | 15.41 | 0.22% |
Inogen Inc | INGN | Medical Devices | 9.12 | 218.10M | -3.80% | n/a | 11.43% |
Neuropace Inc. Common Stock | NPCE | Medical Devices | 6.83 | 199.42M | -1.44% | n/a | 745.17% |
Accuray Incorporated | ARAY | Medical Devices | 1.91 | 191.51M | 7.91% | n/a | 467.45% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
STHO | STHO | Real Estate Services | 13 | 173.15M | -3.20% | n/a | 59.21% |
Douglas Elliman Inc. | DOUG | Real Estate Services | 1.66 | 152.44M | -7.26% | n/a | 62.82% |
Comstock Holding Companies Inc | CHCI | Real Estate Services | 11.7 | 115.38M | 14.71% | 11.75 | 17.12% |
Comstock Mining Inc | LODE | Real Estate Services | 0.521 | 107.66M | 21.16% | 6.09 | 14.37% |
OPAD | OPAD | Real Estate Services | 3.39 | 92.73M | -5.31% | n/a | 406.11% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14 | 87.66M | -1.27% | 14.62 | 7.10% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.02 | 57.65M | -4.67% | n/a | 268.43% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -5.62 | 45.99 | Cheaper |
Ent. to Revenue | 3.48 | 13.20 | Cheaper |
PE Ratio | - | 29.98 | - |
Price to Book | 3.21 | 6.06 | Cheaper |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 69.76 | 66.08 | Par |
Debt to Equity | 0.56 | 0.83 | Cheaper |
Debt to Assets | 0.33 | 0.28 | Par |
Market Cap | 285.81M | 9.42B | Emerging |